You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 3, 2024

Investigational Drug Information for BMS-986166


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for BMS-986166?

BMS-986166 is an investigational drug.

There have been 7 clinical trials for BMS-986166. The most recent clinical trial was a Phase 1 trial, which was initiated on August 16th 2021.

The most common disease conditions in clinical trials are Eczema, Dermatitis, Atopic, and Dermatitis. The leading clinical trial sponsors are Bristol-Myers Squibb and [disabled in preview].

Recent Clinical Trials for BMS-986166
TitleSponsorPhase
A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male ParticipantsBristol-Myers SquibbPhase 1
A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic DermatitisBristol-Myers SquibbPhase 2
A Study to Characterize the Pharmacokinetics of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing PotentialBristol-Myers SquibbPhase 1

See all BMS-986166 clinical trials

Clinical Trial Summary for BMS-986166

Top disease conditions for BMS-986166
Top clinical trial sponsors for BMS-986166

See all BMS-986166 clinical trials

International Patents for BMS-986166

Drugname Country Document Number Estimated Expiration Related US Patent
BMS-986166 Argentina AR101591 2034-08-20 ⤷  Try a Trial
BMS-986166 Australia AU2015305501 2034-08-20 ⤷  Try a Trial
BMS-986166 Brazil BR112017002641 2034-08-20 ⤷  Try a Trial
BMS-986166 Canada CA2958560 2034-08-20 ⤷  Try a Trial
BMS-986166 Chile CL2017000382 2034-08-20 ⤷  Try a Trial
BMS-986166 China CN107148409 2034-08-20 ⤷  Try a Trial
BMS-986166 Colombia CO2017002312 2034-08-20 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.